Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells

Experimental Cell Research

Volumn 342, Issue 2, 2016, Pages 193-199

  Kita, Tsubasa ^a   Kadochi, Yui ^a   Takahashi, Kaede ^a   Fukushima, Kaori ^a   Yamasaki, Eri ^a   Uemoto, Taiki ^a   Hirane, Miku ^a   Fukushima, Nobuyuki ^a   Honoki, Kanya ^b   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell motility; GPR120; GPR40; Invasion; Lung cancer

Indexed keywords

CISPLATIN; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; GELATIN; GELATINASE A; GELATINASE B; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; FFAR1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GW1100; GW9508; METHYLAMINE; MMP2 PROTEIN, HUMAN; O3FAR1 PROTEIN, HUMAN; PROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

A549 CELL LINE; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG CANCER CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; ZYMOGRAPHY; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; ENDOTHELIUM CELL; GENE SILENCING; METABOLISM; MOUSE; PHYSIOLOGY; RAT; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOATES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 2; METHYLAMINES; MICE; PROPIONATES; PYRIMIDINES; RATS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84960156185     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2016.03.008     Document Type: Article

References (28)

1. Pierce K.J., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3:639-650.
2. Rosenbaum D.M., Rasmussen S.G., Kobilka B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
3. Venkatakrishnan A.J., Deupi X., Lebon G., Tate C.G., Schertler G.F., Babu M.M. Molecular signatures of G-protein-coupled receptors. Nature 2013, 494:185-194.
4. Brown A.J., Jupe S., Briscoe C.P. A family of fatty acid binding receptors. DNA Cell Biol. 2005, 24:54-61.
5. Hara T., Hirasawa A., Ichimura A., Kimura I., Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J. Pharm. Sci. 2011, 100:3594-3601.
6. Hara T., Kimura I., Inoue D., Ichimura A., Hirasawa A. Free fatty acid receptors and their role in regulation of energy metabolism. Rev. Physiol. Biochem. Pharmacol. 2013, 164:77-116.
7. Fukunaga S., Setoguchi S., Hirasawa A., Tsujimoto G. Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach. Life Sci. 2006, 80:17-23.
8. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., Murdock P.R., Sauls H.R., Shabon U., Spinage L.D., Strum J.C., Szekeres P.G., Tan K.B., Way J.M., Ignar D.M., Wilson S., Muir A.I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003, 278:11303-11311.
9. Miyauchi S., Hirasawa A., Iga T., Liu N., Itsubo C., Sadakane K., Hara T., Tsujimoto G. Distribution and regulation of protein expression of the free fatty acid receptor GPR120. Naunyn Schmiede. Arch. Pharmacol. 2009, 379:427-434.
10. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G. Free fatty acids regulate gut Incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 2005, 11:90-94.
11. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003, 422:173-176.
12. Hara T., Kashihara D., Ichimura A., Kimura I., Tsujimoto G., Hirasawa A. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim Biophys. Acta 1841, 2014:1292-1300.
13. Cornall L.M., Mathai M.L., Hryciw D.H., McAinch A.J. GPR120 agonism as a countermeasure against metabolic diseases. Drug Discov. Today 2014, 19:670-679.
14. Ichimura A., Hasegawa S., Kasubuchi M., Kimura I. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 2014, 5:1-6.
15. Wu Q., Wang H., Zhao X., Shi Y., Jin M., Wan B., Xu H., Cheng Y., Ge H., Zhang Y. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 2013, 32:5541-5550.
16. Ishii S., Kitamura Y., Hirane M., Tomimatsu A., Fukushima K., Takahashi K., Fukushima N., Honoki K., Tsujiuchi T. Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells. Mol. Carcinog. 2015, 10.1002/mc.22408.
17. Fukushima K., Yamasaki E., Ishii S., Tomimatsu A., Takahashi K., Hirane M., Fukushima N., Honoki K., Tsujiuchi T. Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2015, 465:512-515.
18. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2013, 63:11-30.
19. 6 on the activation of tumor progression in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2015, 461:59-64.
20. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., Murdock P.R., Sauls H.R., Shabon U., Spinage L.D., Strum J.C., Szekeres P.G., Tan K.B., Way J.M., Ignar D.M., Wilson S., Muir A.I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003, 278:11303-11311.
21. Briscoe C.P., Peat A.J., McKeown S.C., Corbett D.F., Goetz A.S., Littleton T.R., McCoy D.C., Kenakin T.P., Andrews J.L., Ammala C., Fornwald J.A., Ignar D.M., Jenkinson S. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br. J. Pharmacol. 2006, 148:619-628.
22. Bharate S.B., Nemmani K.V., Vishwakarma R.A. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes. Expert Opin. Ther. Pat. 2009, 19:237-264.
23. Chekhun V.F., Lukyanova N.Y., Kovalchuk O., Tryndyak V.P., Pogribny I.P. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol. Cancer Ther. 2007, 6:1089-1098.
24. Edfalk S., Steneberg P., Ediund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stumjulation on Incretin secretion. Diabetes 2008, 57:2280-22287.
25. Tomita T., Masuzaki H., Iwakura H., Fujikura J., Noguchi M., Tanaka T., Ebihara K., Kawamura J., Komoto I., Kawaguchi Y., Fujimoto K., Doi R., Shimada Y., Hosoda K., Imamura M., Nakao K. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumors in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia 2006, 49:962-968.
26. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
27. Tozer G.M., Kanthou C., Baguley B.C. Disrupting tumor blood vessels. Nat. Rev. Cancer 2005, 5:423-435.
28. Liu J., Mazzone P.J., Cata J.P., Kurz A., Bauer M., Mascha E.J., Sessler D.I. Serum free fatty acid biomarkers of lung cancer. Chest 2014, 146:670-679.